IDO upregulates regulatory T cells via tryptophan catabolite and suppresses encephalitogenic T cell responses in experimental autoimmune encephalomyelitis
about
Kynurenines in CNS disease: regulation by inflammatory cytokinesThe environment of regulatory T cell biology: cytokines, metabolites, and the microbiomeThe Notch signaling regulates CD105 expression, osteogenic differentiation and immunomodulation of human umbilical cord mesenchymal stem cellsCurrent Evidence for a Role of the Kynurenine Pathway of Tryptophan Metabolism in Multiple SclerosisRegulatory T Cells: Molecular Actions on Effector Cells in Immune RegulationThe Role of Indoleamine 2, 3-Dioxygenase in Immune Suppression and AutoimmunityMetabolic reprogramming and metabolic dependency in T cellsImmunoregulatory molecules are master regulators of inflammation during the immune responseThe relationship between metabolism and the autophagy machinery during the innate immune responseThe role of dendritic cells and monocytes in the maintenance and loss of respiratory toleranceThe Kynurenine Pathway Is a Double-Edged Sword in Immune-Privileged Sites and in Cancer: Implications for ImmunotherapyImmune privilege as an intrinsic CNS property: astrocytes protect the CNS against T-cell-mediated neuroinflammationHyperoxygenation attenuated a murine model of atopic dermatitis through raising skin level of ROSThe role of placental tryptophan catabolismRegulatory T cells in multiple sclerosis and myasthenia gravis.GM-CSF-neuroantigen fusion proteins reverse experimental autoimmune encephalomyelitis and mediate tolerogenic activity in adjuvant-primed environments: association with inflammation-dependent, inhibitory antigen presentation.IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and ToleranceThe relationship between indoleamine 2,3-dioxygenase activity and post-stroke cognitive impairment.Interferon gamma suppresses collagen-induced arthritis by regulation of Th17 through the induction of indoleamine-2,3-deoxygenase.Quinolinic acid toxicity on oligodendroglial cells: relevance for multiple sclerosis and therapeutic strategies.Metabolic Control of Th17 Cell Generation and CNS InflammationReactive oxygen species prevent imiquimod-induced psoriatic dermatitis through enhancing regulatory T cell functionInduction of indoleamine 2, 3-dioxygenase in human dendritic cells by a cholera toxin B subunit-proinsulin vaccine.Amino acid catabolism: a pivotal regulator of innate and adaptive immunity.The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysisSilencing IFN-γ binding/signaling in astrocytes versus microglia leads to opposite effects on central nervous system autoimmunity.Immune modulation by Lacto-N-fucopentaose III in experimental autoimmune encephalomyelitis.Expression of the Kynurenine Pathway in Human Peripheral Blood Mononuclear Cells: Implications for Inflammatory and Neurodegenerative DiseaseIDO1 Deficiency Does Not Affect Disease in Mouse Models of Systemic Juvenile Idiopathic Arthritis and Secondary Hemophagocytic Lymphohistiocytosis.Anti-inflammatory mechanisms of IFN-γ studied in experimental autoimmune encephalomyelitis reveal neutrophils as a potential target in multiple sclerosis.Differential Transcriptome Networks between IDO1-Knockout and Wild-Type Mice in Brain Microglia and Macrophages.CNS-specific therapy for ongoing EAE by silencing IL-17 pathway in astrocytesThe Deficiency of Indoleamine 2,3-Dioxygenase Aggravates the CCl4-Induced Liver Fibrosis in MiceBrain indoleamine 2,3-dioxygenase contributes to the comorbidity of pain and depressionAllosteric modulation of metabotropic glutamate receptor 4 activates IDO1-dependent, immunoregulatory signaling in dendritic cells.Metabolic control of the Treg/Th17 axisRole of regulatory T cell in clinical outcome of traumatic brain injury.Blockage of indoleamine 2,3-dioxygenase regulates Japanese encephalitis via enhancement of type I/II IFN innate and adaptive T-cell responses.Indoleamine 2,3-dioxygenase and dendritic cell tolerogenicity.The control of the specificity of CD4 T cell responses: thresholds, breakpoints, and ceilings
P2860
Q21129356-606A145A-BE08-4E6C-B182-182F749B3094Q21131158-7D29D815-72AA-461B-8B68-720FBB1FA469Q23922359-7418AC73-F5D9-44BE-B8E1-6924C2AFF472Q26740330-4928E3E2-92EE-43D8-AF71-92E78919DFA1Q26746113-DD8EF34F-66C1-4EDB-8D20-044B4AACA484Q26785900-727C8C80-DEED-4B7D-8974-ED64316C0254Q26864319-5A663DBF-636E-4302-BCC3-2F475FD2F2FBQ27022027-1DA34489-72C9-46C2-B1D3-5CD1A88C3CFAQ27024153-B6E443C6-DBEF-4883-84F7-571E34C067EEQ27030817-BB3F3D0B-285E-462C-AEFC-41E5FEBB7859Q28073631-ED6D7C75-B029-4EF4-AE2E-67339FFD1029Q28298280-A783CC17-63A2-48C2-AFA6-17BB9C911E7BQ28543509-877F2F6E-51AB-4DC9-9F9B-E8430BE2F0E2Q33657987-FF8DD339-0DBE-41AA-A7E8-EECA85F303E4Q33784969-3A7AC808-10D1-476D-9D5C-E1D0444EEA91Q34065039-45EBE471-6CAF-49E5-8FAE-2DB5010400D7Q34512092-3F906AAF-2AF4-4FD9-B1D0-BBE4EC064B4BQ34662653-B122E6C3-AA51-4633-9BB0-9065FBB29E17Q34683824-716916A7-4477-4F78-A1DF-A5DA91941393Q34997869-07BD3878-DB73-44C1-9258-A23C5A6871F2Q35101158-1AFE025D-9A52-4298-A4F7-6DDDB286F8DEQ35114429-9E37C0FF-B227-49AB-ACB8-404EE9B05507Q35122841-2021B139-29FC-49DE-8B00-EC35B7A8A0B4Q35261125-A59322F6-24BD-4F22-933B-71188E92AEE5Q35356649-96941038-8497-4BA5-A360-9B268E0E4174Q35472172-4189D32C-3B92-4B3A-BF02-C6E0018E0877Q35784305-CAD80470-483F-4AE7-B636-47F060F963D8Q35788146-A773B440-1DC5-40C0-8DFE-0E58BF47B2BFQ35935473-FC04DE0F-B804-4E34-939D-0FAE0ECDBD34Q35964276-266CF261-946B-4044-8397-3BDEDF9A06BCQ36055343-734BD838-369B-4DEF-B6E7-B660DC0EEAD9Q36085387-A8C74BF6-8580-48B5-BDDA-55CF46EEB7ABQ36124069-6F99C94C-5376-4BD8-956F-2AB15A02D3F6Q36129070-6CC84A67-16F8-4D41-932D-17E726AEFB7DQ36482311-005A8105-09C0-4CBE-AE02-7EF0A33BDEE8Q36622931-30159D7B-A99A-4200-8744-3DF89AE5D595Q36801440-B3CF922A-F90E-4D94-BF9B-C2BA7CE0C29BQ36810606-F0E687D6-C40D-4762-95B7-3F97CB11E8FFQ36821053-57F7D85A-4038-468D-9F1F-F8790CA2A7E5Q37249406-B8D8E216-2323-4ED4-A087-EAC594BEDAAD
P2860
IDO upregulates regulatory T cells via tryptophan catabolite and suppresses encephalitogenic T cell responses in experimental autoimmune encephalomyelitis
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
IDO upregulates regulatory T c ...... l autoimmune encephalomyelitis
@ast
IDO upregulates regulatory T c ...... l autoimmune encephalomyelitis
@en
IDO upregulates regulatory T c ...... l autoimmune encephalomyelitis
@nl
type
label
IDO upregulates regulatory T c ...... l autoimmune encephalomyelitis
@ast
IDO upregulates regulatory T c ...... l autoimmune encephalomyelitis
@en
IDO upregulates regulatory T c ...... l autoimmune encephalomyelitis
@nl
prefLabel
IDO upregulates regulatory T c ...... l autoimmune encephalomyelitis
@ast
IDO upregulates regulatory T c ...... l autoimmune encephalomyelitis
@en
IDO upregulates regulatory T c ...... l autoimmune encephalomyelitis
@nl
P2093
P2860
P356
P1476
IDO upregulates regulatory T c ...... l autoimmune encephalomyelitis
@en
P2093
Abdolmohamad Rostami
Bruno Gran
Francesca Fallarino
Guang-Xian Zhang
Hongmei Li
Melissa L Cullimore
Yaping Yan
P2860
P304
P356
10.4049/JIMMUNOL.1001628
P407
P577
2010-10-13T00:00:00Z